Similar Items: Characterization of and risk factors for HIV-1 resistance mutations following first line antiretroviral failure in the southern African private sector
- Resistance to first line anti-TB drugs by gene mutation and gene modulation
- Predicting early and late first-line antiretroviral therapy virologic failure, and switch to second-line therapy in a military population in South Africa
- Antiretroviral therapy adherence and effectiveness in a private sector disease management programme in Southern Africa
- Tenofovir based regimens associated with less drug resistance in hiv-1 infected nigerians failing first-line antiretroviral therapy.
- Cost effectiveness analysis of two alternative interventions for the integration of Tenofovir into South Africa's public sector First Line Antiretroviral treatment regimen
- Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy
Author: Meintjes, Graeme
- The immunomodulatory role of prednisone in patients with HIV-associated tuberculosis and assessment of its impact on lung function outcome
- Investigating the molecular pathogenesis of tuberculosis-associated immune reconstitution inflammatory syndrome
- Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
- Characterization of and risk factors for HIV-1 resistance mutations following first line antiretroviral failure in the southern African private sector
- Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: A retrospective cohort study
- Diagnosis, treatment and immunopathogenesis of the HIV-associated tuberculosis immune reconstitution inflammatory syndrome